NCT03361111View on ClinicalTrials.gov

BIOmarkers in Severe AsthMa Patients on Omalizumab Treatment

CompletedOBSERVATIONAL

Enrollment

16

Participants

Timeline

Start Date

April 4, 2013

Primary Completion Date

November 5, 2018

Study Completion Date

December 30, 2018

Conditions

Severe Asthma

Trial Locations (1)

00-707

Joanna Hermanowicz-Salamon, Warsaw

All Listed Sponsors

lead

Medical University of Warsaw

OTHER

NCT03361111 - BIOmarkers in Severe AsthMa Patients on Omalizumab Treatment | Biotech Hunter | Biotech Hunter